Expanding health care services for HIV, tuberculosis, and malaria has increased the demand for affordable and reliable laboratory diagnostics in resource-limited countries. Many countries are responding by upgrading their public laboratories and introducing new technology to provide expanded testing services into more regions. This expansion carries the risk of increasing the diversity of an already highly diverse technology and testing platform landscape, making it more difficult to manage laboratory networks across different levels of the health care system.
View Article and Find Full Text PDFCytometry B Clin Cytom
May 2008
The scale-up of HIV antiretroviral therapy in recent years has led to a rapid increase in CD4 and CD4% count capacity to meet the diagnostic needs of staging and monitoring disease progression and treatment efficacy in adults and infants. The speed of implementation of this technology has been unrivalled in recent years and has met challenges with technology selection, laboratory infrastructure development, human resource limitations, cost-effectiveness, instrument maintenance, and ensuring testing access and quality. The lessons learned from dealing with these challenges have helped strengthen existing laboratory systems for other diagnostics.
View Article and Find Full Text PDF